Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

Arteriosclerosis, Thrombosis, and Vascular Biology
Dominick J AngiolilloCarlos Macaya

Abstract

Metabolic activity of cytochrome P450 (CYP) 3A4 has been associated with clopidogrel response variability. Because metabolic activity of CYP3A4 is genetically regulated, we hypothesized that genetic variations of this enzyme may contribute to clopidogrel response variability. The CYP3A4*1B, CYP3A4*3, IVS7+258A>G, IVS7+894C>T, and IVS10+12G>A polymorphisms of the CYP3A4 gene were assessed in 82 patients in a steady phase of clopidogrel therapy. Glycoprotein (platelet glycoprotein (GP) IIb/IIIa receptor activation and platelet aggregation were assessed. A cohort of 45 clopidogrel-naïve patients was studied to determine the modulating effects of these polymorphisms after loading dose (300 mg) administration. Only the IVS7+258A>G, IVS7+894C>T, and IVS10+12G>A polymorphisms were sufficiently polymorphic. During the steady phase of clopidogrel treatment, IVS10+12A allele carriers had reduced GP IIb/IIIa activation (P=0.025) and better responsiveness (P=0.02); similarly, clopidogrel-naïve patients carriers of the IVS10+12A allele had reduced GP IIb/IIIa activation during the first 24 hours after a loading dose (P=0.025), increased platelet inhibition (P=0.006), and a more optimal drug response (P=0.003). This polymorphism did not infl...Continue Reading

References

Nov 1, 1988·Genetics·R C Lewontin
Mar 5, 2002·Pharmacogenetics·Jatinder K LambaErin G Schuetz
Oct 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jean-Marie PereilloClaudine Picard
Oct 31, 2002·Advanced Drug Delivery Reviews·Jatinder K LambaKenneth E Thummel
Dec 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thomas A Clarke, Lucy A Waskell
Dec 20, 2003·Nature·UNKNOWN International HapMap Consortium
Jul 2, 2004·Therapeutic Drug Monitoring·Leszek Wojnowski
Jul 23, 2004·Thrombosis and Haemostasis·Dirk TaubertEdgar Schömig
Jan 18, 2005·Journal of the American College of Cardiology·Victor L SerebruanyEric J Topol
Mar 30, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Nicolas von BeckerathAdnan Kastrati
Apr 20, 2005·Journal of the American College of Cardiology·Thuy Anh NguyenChantal Pharand
Apr 27, 2005·Seminars in Thrombosis and Hemostasis·J J J van Giezen, Robert G Humphries
Nov 16, 2005·Journal of the American College of Cardiology·Paul A GurbelUdaya S Tantry
Nov 16, 2005·Journal of the American College of Cardiology·Paul A GurbelUdaya S Tantry

❮ Previous
Next ❯

Citations

Nov 28, 2009·Basic Research in Cardiology·Philipp DiehlMartin Moser
Dec 31, 2011·Human Genetics·Thomas CuissetMarie-Christine Alessi
Mar 8, 2011·Molecular Biology Reports·Isabelle Djaffar JureidiniNoha Hakime
Jul 19, 2008·Journal of Thrombosis and Thrombolysis·Silvia RiondinoFrancesco Barillà
Jan 9, 2009·Internal and Emergency Medicine·Giuseppe Patti, Germano Di Sciascio
May 26, 2009·JACC. Cardiovascular Interventions·Dean J Kereiakes, Paul A Gurbel
Oct 22, 2013·Vascular Pharmacology·N L HurstJ D Horowitz
Jan 24, 2009·The New England Journal of Medicine·Jane E Freedman, Elaine M Hylek
Dec 25, 2008·The New England Journal of Medicine·Tabassome SimonUNKNOWN French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators
Dec 25, 2008·The New England Journal of Medicine·Jessica L MegaMarc S Sabatine
Jul 30, 2009·European Heart Journal·Céline VerstuyftRichard B Kim
Sep 14, 2010·European Heart Journal·Ankie M HarmszeVera H M Deneer
Jun 18, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·James P EvansMuin Khoury
Jun 17, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Zuzana MotovskaUNKNOWN PRAGUE-8 study investigators
Mar 19, 2008·Clinical and Experimental Pharmacology & Physiology·Bi-Lian ChenHong-Hao Zhou
May 6, 2011·Thrombosis and Haemostasis·H FernandoJ A Shaw
Sep 7, 2007·BMC Medical Genetics·Ugo CavallariPier Franco Pignatti
Jun 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Lukasz A MalekGrzegorz Opolski
Jun 18, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Toshikazu JinnaiTakeshi Kimura
Nov 26, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Takahiro SawadaKen-ichi Hirata
Mar 17, 2010·Future Cardiology·Kathryn M Momary, Michael P Dorsch
May 14, 2010·Future Cardiology·Richard L SeipGualberto Ruaño
Mar 28, 2013·Cardiology Research and Practice·Adriana Dana Oprea, Wanda M Popescu
Apr 26, 2014·Future Cardiology·Licia IacovielloGiovanni de Gaetano
May 8, 2009·Expert Review of Cardiovascular Therapy·Shiny Mathewkutty, Darren K McGuire
Jul 16, 2015·Expert Opinion on Drug Metabolism & Toxicology·Yao YangStuart A Scott
May 7, 2009·Expert Opinion on Drug Metabolism & Toxicology·Iris Grossman
Dec 9, 2009·Expert Opinion on Drug Metabolism & Toxicology·Minoli A Perera
Jul 7, 2009·Expert Opinion on Drug Metabolism & Toxicology·Paul A GurbelUdaya S Tantry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.